Clinical Manifestations and Treatment of Migraine
Migraine is characterized by recurrent episodes of moderate to severe headache lasting 4 to 72 hours, typically with pulsating quality, often accompanied by nausea, vomiting, photophobia, and phonophobia, which can significantly impact quality of life and daily functioning. 1, 2
Clinical Manifestations
Headache Characteristics
- Location: Often unilateral, though population-based data indicate ~40% report bilateral pain 1
- Quality: Typically pulsating or throbbing 1
- Intensity: Moderate to severe, worsening with routine physical activity 1
- Duration: 4-72 hours if untreated 1, 2
Associated Symptoms
- Sensory sensitivities: Photophobia (light sensitivity), phonophobia (sound sensitivity) 1
- Gastrointestinal: Nausea, vomiting 1
- Prodromal symptoms: May include depressed mood, yawning, fatigue, food cravings 1
- Postdromal symptoms: Can last up to 48 hours and include tiredness, concentration difficulties, neck stiffness 1
Migraine with Aura
- Approximately one-third of individuals experience aura 1
- Visual aura occurs in >90% of affected individuals, classically as fortification spectra 1
- Sensory symptoms occur in ~31%, usually as unilateral paresthesia that spreads gradually 1
- Less common: aphasic speech disturbance, brainstem symptoms, motor weakness 1
Treatment Approaches
Acute Treatment
First-line medications for mild to moderate attacks:
For moderate to severe attacks:
Triptan options:
For migraine with significant nausea/vomiting:
Alternative options:
Preventive Treatment
Consider preventive therapy when:
- Attacks occur ≥4 times per month 2
- Attacks cause significant disability 2
- Acute treatments are ineffective or contraindicated 2
- Patient has frequent or disabling headaches 2
- Medication overuse is present 2
First-line preventive medications:
- Beta-blockers: Propranolol (80-240 mg/day), Timolol (20-30 mg/day) 2
- Antidepressants: Amitriptyline (30-150 mg/day) 2
- Anticonvulsants: Topiramate, Divalproex sodium (500-1500 mg/day), Sodium valproate (800-1500 mg/day) 2
Second/third-line options:
- CGRP monoclonal antibodies (erenumab, fremanezumab, galcanezumab, eptinezumab) 2
- Angiotensin-converting enzyme inhibitors and angiotensin II–receptor blockers (used off-label) 1
Lifestyle Modifications and Supplemental Therapies
Regular habits: Maintain consistent sleep patterns, meal times, and hydration 2
Physical activity: Regular exercise can help reduce frequency and intensity of headaches 2
Caffeine management: Limit caffeine intake 2
Stress management: Implement cognitive-behavioral therapy, biofeedback, relaxation training 2
Supplements with modest efficacy:
- Magnesium
- Riboflavin (Vitamin B2)
- Feverfew 2
Monitoring and Avoiding Complications
- Assess response to preventive treatment after 2-3 months 2
- Limit acute medications to ≤10 days per month to prevent medication overuse headache 2
- Consider referral to a neurologist if headaches remain refractory to multiple treatment options 2
- Consider neuroimaging (CT or MRI) for patients with abnormal neurological examination, atypical headache features, or other red flags 2
Common Pitfalls to Avoid
Underdiagnosis and undertreatment: Migraine is often underdiagnosed and undertreated, with only a small percentage of eligible patients receiving appropriate preventive treatments 1, 4
Medication overuse: Excessive use of acute medications (>10 days/month) can lead to medication overuse headache, which can transform episodic migraine into chronic daily headache 2, 4
Inappropriate acute treatment: Using inadequate doses or inappropriate medications for severe attacks can lead to poor outcomes 2
Delayed treatment: Taking medications early in an attack is more effective than waiting until pain is severe 5
Failure to address comorbidities: Managing comorbid conditions is essential for optimal migraine control 2
By understanding the clinical manifestations and implementing appropriate treatment strategies based on headache severity and frequency, clinicians can significantly improve outcomes for patients with migraine.